A meta-analysis analyzing the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in previously treated patients with non-small cell lung cancer (NSCLC).

Authors: Deevyashali Parekh, Devashish Desai, Parth J. Sampat, Anuja Vidyadhar Abhyankar, Shweta Paulraj, Ayushi Shah, Prashanth Ashok Kumar

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20674

Source: Full article

---

Abstract

e20674